Late Breaking Abstract An Open-Label, Phase Ii Basket Study Of Olaparib And Durvalumab (Mediola): Results In Germline Brca-Mutated (Gbrcam) Platinum-Sensitive Relapsed (Psr) Ovarian Cancer (Oc)
GYNECOLOGIC ONCOLOGY（2018）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要